Zurex Pharma Inc. has raised more than $6 million of outside funding, the Middleton developer of products to help prevent infections in health care settings said.

The funding was raised from current shareholders and new investors. Zurex will use the money to support late-stage clinical trials of its primary compound and for general purposes, the company said in a news release. Read the full story here.

See the SEC filing here.

Read the Xconomy story here.